KeyBanc analyst Brett Fishbin raised the firm’s price target on ICU Medical (ICUI) to $180 from $175 and keeps an Overweight rating on the shares given higher estimates. The firm believes ICU remains well positioned into 2026, and views an in-line initial 2026 outlook as an achievable starting point.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICUI: